Brief: Everest Medicines Entered Strategic Commercial Partnership With Tencent Holdings Ltd
12/07/2021 02:14
July 12 (Reuters) - Everest Medicine Ltd 1952.HK :
* ENTERED INTO STRATEGIC COMMERCIAL PARTNERSHIP WITH TENCENT
HOLDINGS LTD
* PARTNERSHIP TO EXPLORE WAYS TO OPTIMIZE MEANINGFUL DIGITAL
ENGAGEMENT WITH PATIENTS AND HEALTHCARE PROVIDER
* CO AND TENCENT WILL CONSIDER OPTIONS TO BUILD A ONE-STOP
PATIENT
MANAGEMENT ECOSYSTEM
Source text for Eikon: ID:nHKS9ywPhb
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region